Article contents
Clinically relevant reduction of lamotrigine concentrations by carbamazepine
Published online by Cambridge University Press: 16 April 2020
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Short communication
- Information
- Copyright
- Copyright © Éditions scientifiques et médicales Elsevier SAS 2003
References
Ebert, U, Thong, NQ, Oertel, R, Kirch, WEffects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamot-rigine in healthy subjects. Eur J Clin Pharmacol 2000;56:299–304.CrossRefGoogle ScholarPubMed
Hachad, H, Ragueneau-Majlessi, I, Levy, RHNew antiepileptic drugs: review on drug interactions. Ther Drug Monit 2002;24:91–103.CrossRefGoogle ScholarPubMed
Harden, CSafety profile of levetiracetam. Epilepsia 2001;42(Suppl 4):36–9.CrossRefGoogle ScholarPubMed
Janowsky, DS. New treatments of bipolar disorder. Curr Psychiatry Rep 1999;1:111–3.CrossRefGoogle ScholarPubMed
Pihlsgard, M, Eliasson, ESignificant reduction of sertraline plasma levels by carbamazepine and phenytoin. Eur J Clin Pharmacol 2002 [Online 23 January 2002].CrossRefGoogle ScholarPubMed
Shah, MM, Balaran, REffect of phenobarbitone, carbamazepine and sodium valproate on the elimination kinetics of acetaminophen. Indian J Pharmacol 1999;31:311–4.Google Scholar
- 4
- Cited by
Comments
No Comments have been published for this article.